Cargando…
A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620723/ https://www.ncbi.nlm.nih.gov/pubmed/34832520 http://dx.doi.org/10.3390/pathogens10111364 |
_version_ | 1784605288832172032 |
---|---|
author | Tiecco, Giorgio Degli Antoni, Melania Storti, Samuele Marchese, Valentina Focà, Emanuele Torti, Carlo Castelli, Francesco Quiros-Roldan, Eugenia |
author_facet | Tiecco, Giorgio Degli Antoni, Melania Storti, Samuele Marchese, Valentina Focà, Emanuele Torti, Carlo Castelli, Francesco Quiros-Roldan, Eugenia |
author_sort | Tiecco, Giorgio |
collection | PubMed |
description | In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease. |
format | Online Article Text |
id | pubmed-8620723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86207232021-11-27 A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines Tiecco, Giorgio Degli Antoni, Melania Storti, Samuele Marchese, Valentina Focà, Emanuele Torti, Carlo Castelli, Francesco Quiros-Roldan, Eugenia Pathogens Review In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease. MDPI 2021-10-21 /pmc/articles/PMC8620723/ /pubmed/34832520 http://dx.doi.org/10.3390/pathogens10111364 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tiecco, Giorgio Degli Antoni, Melania Storti, Samuele Marchese, Valentina Focà, Emanuele Torti, Carlo Castelli, Francesco Quiros-Roldan, Eugenia A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines |
title | A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines |
title_full | A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines |
title_fullStr | A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines |
title_full_unstemmed | A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines |
title_short | A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines |
title_sort | 2021 update on syphilis: taking stock from pathogenesis to vaccines |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620723/ https://www.ncbi.nlm.nih.gov/pubmed/34832520 http://dx.doi.org/10.3390/pathogens10111364 |
work_keys_str_mv | AT tieccogiorgio a2021updateonsyphilistakingstockfrompathogenesistovaccines AT degliantonimelania a2021updateonsyphilistakingstockfrompathogenesistovaccines AT stortisamuele a2021updateonsyphilistakingstockfrompathogenesistovaccines AT marchesevalentina a2021updateonsyphilistakingstockfrompathogenesistovaccines AT focaemanuele a2021updateonsyphilistakingstockfrompathogenesistovaccines AT torticarlo a2021updateonsyphilistakingstockfrompathogenesistovaccines AT castellifrancesco a2021updateonsyphilistakingstockfrompathogenesistovaccines AT quirosroldaneugenia a2021updateonsyphilistakingstockfrompathogenesistovaccines AT tieccogiorgio 2021updateonsyphilistakingstockfrompathogenesistovaccines AT degliantonimelania 2021updateonsyphilistakingstockfrompathogenesistovaccines AT stortisamuele 2021updateonsyphilistakingstockfrompathogenesistovaccines AT marchesevalentina 2021updateonsyphilistakingstockfrompathogenesistovaccines AT focaemanuele 2021updateonsyphilistakingstockfrompathogenesistovaccines AT torticarlo 2021updateonsyphilistakingstockfrompathogenesistovaccines AT castellifrancesco 2021updateonsyphilistakingstockfrompathogenesistovaccines AT quirosroldaneugenia 2021updateonsyphilistakingstockfrompathogenesistovaccines |